Bishop NJ - Search Results

1

Cyclic administration of pamidronate in children with severe osteogenesis imperfecta.

Glorieux FH, Bishop NJ, Plotkin H, Chabot G, Lanoue G, Travers R. Glorieux FH, et al. Among authors: bishop nj. N Engl J Med. 1998 Oct 1;339(14):947-52. doi: 10.1056/NEJM199810013391402. N Engl J Med. 1998. PMID: 9753709 Free article. Clinical Trial.

2

Interpretation of bone mineral density values in pediatric Crohn's disease.

Herzog D, Bishop N, Glorieux F, Seidman EG. Herzog D, et al. Inflamm Bowel Dis. 1998 Nov;4(4):261-7. doi: 10.1002/ibd.3780040402. Inflamm Bowel Dis. 1998. PMID: 9836077 Clinical Trial.

3

Perinatal metabolism of vitamin D.

Salle BL, Delvin EE, Lapillonne A, Bishop NJ, Glorieux FH. Salle BL, et al. Among authors: bishop nj. Am J Clin Nutr. 2000 May;71(5 Suppl):1317S-24S. doi: 10.1093/ajcn/71.5.1317s. Am J Clin Nutr. 2000. PMID: 10799409 Review.

4

Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age.

Plotkin H, Rauch F, Bishop NJ, Montpetit K, Ruck-Gibis J, Travers R, Glorieux FH. Plotkin H, et al. Among authors: bishop nj. J Clin Endocrinol Metab. 2000 May;85(5):1846-50. doi: 10.1210/jcem.85.5.6584. J Clin Endocrinol Metab. 2000. PMID: 10843163 Clinical Trial.

5

Type V osteogenesis imperfecta: a new form of brittle bone disease.

Glorieux FH, Rauch F, Plotkin H, Ward L, Travers R, Roughley P, Lalic L, Glorieux DF, Fassier F, Bishop NJ. Glorieux FH, et al. Among authors: bishop nj. J Bone Miner Res. 2000 Sep;15(9):1650-8. doi: 10.1359/jbmr.2000.15.9.1650. J Bone Miner Res. 2000. PMID: 10976985 Free article. Clinical Trial.

6

Intravenous pamidronate treatment in children with moderate to severe osteogenesis imperfecta: assessment of indices of dual-energy X-ray absorptiometry and bone metabolic markers during the first year of therapy.

Arikoski P, Silverwood B, Tillmann V, Bishop NJ. Arikoski P, et al. Among authors: bishop nj. Bone. 2004 Mar;34(3):539-46. doi: 10.1016/j.bone.2003.11.019. Bone. 2004. PMID: 15003801

7

Special report on the 2007 Pediatric Position Development Conference of the International Society for Clinical Densitometry.

Gordon CM, Baim S, Bianchi ML, Bishop NJ, Hans DB, Kalkwarf H, Langman C, Leonard MB, Plotkin H, Rauch F, Zemel BS; International Society for Clinical Densitometry. Gordon CM, et al. Among authors: bishop nj. South Med J. 2008 Jul;101(7):740-3. doi: 10.1097/SMJ.0b013e31817a8b55. South Med J. 2008. PMID: 18580718

8

Characterising and treating osteogenesis imperfecta.

Bishop N. Bishop N. Early Hum Dev. 2010 Nov;86(11):743-6. doi: 10.1016/j.earlhumdev.2010.08.002. Epub 2010 Sep 16. Early Hum Dev. 2010. PMID: 20846798

9

Enzyme-replacement therapy in life-threatening hypophosphatasia.

Whyte MP, Greenberg CR, Salman NJ, Bober MB, McAlister WH, Wenkert D, Van Sickle BJ, Simmons JH, Edgar TS, Bauer ML, Hamdan MA, Bishop N, Lutz RE, McGinn M, Craig S, Moore JN, Taylor JW, Cleveland RH, Cranley WR, Lim R, Thacher TD, Mayhew JE, Downs M, Millán JL, Skrinar AM, Crine P, Landy H. Whyte MP, et al. Among authors: bishop n. N Engl J Med. 2012 Mar 8;366(10):904-13. doi: 10.1056/NEJMoa1106173. N Engl J Med. 2012. PMID: 22397652 Free article. Clinical Trial.

10

Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial.

Bishop N, Adami S, Ahmed SF, Antón J, Arundel P, Burren CP, Devogelaer JP, Hangartner T, Hosszú E, Lane JM, Lorenc R, Mäkitie O, Munns CF, Paredes A, Pavlov H, Plotkin H, Raggio CL, Reyes ML, Schoenau E, Semler O, Sillence DO, Steiner RD. Bishop N, et al. Lancet. 2013 Oct 26;382(9902):1424-32. doi: 10.1016/S0140-6736(13)61091-0. Epub 2013 Aug 6. Lancet. 2013. PMID: 23927913 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

178 results

Search Page